Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kyowa Kirin Co., Ltd.

Clinical trials sponsored by Kyowa Kirin Co., Ltd., explained in plain language.

Now part of Kyowa Kirin Co., Ltd. 4151 TOKYO

Pharmaceutical company focused on specialty medicines.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 8 Not yet finished but already full! 6 Completed 1

New pill shows promise for Hard-to-Treat blood cancer in early japanese study

Disease control Completed

This early-phase study tested a new oral drug called ME-401 in 14 Japanese patients with a slow-growing form of non-Hodgkin's lymphoma that had returned or stopped responding to prior treatments. The main goals were to check the drug's safety, find the right dose, and see how the…

Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC